Decheng Capital

  • About Us
  • Team
  • Portfolio
  • News
  • Contact

A Global Life Sciences Investment Firm

Established in 2012

$2.1 Billion of Capital

Building Legendary Companies

In The News

December 16, 2021 Anheart Therapeutics Raises $61M in Series B for Precision Oncology Pipeline
November 16, 2021 ACELYRIN, INC. Closes $250 Million Series B Financing and Announces Licensing of Izokibep
October 26, 2021 Vertex signs another Mammoth-sized CRISPR deal with $650M in Biobucks on the Line
September 24, 2021 Google Provider of At-home Covid-19 tests is Now a $3 Billion Company Traded on Nasdaq
September 20, 2021 Pacific Biosciences Closes Acquisition of Omniome and Establishes San Diego Presence
September 15, 2021 Alpine Immune Sciences Announces $91 Million Private Placement
September 9, 2021 Mammoth Biosciences Raises $195 Million to Build Next-Generation CRISPR Products in Therapeutics and Diagnostics
August 27, 2021 Lynk Pharmaceuticals Announces the Completion of Series B Financing of $50 Million
August 26, 2021 Aadi Bioscience Announces Closing of Merger with Aerpio Pharmaceuticals and $155M Private Placement
August 26, 2021 BeyondSpring Announces Exclusive Commercialization And Co-Development Agreement With Jiangsu Hengrui Pharmaceuticals For Plinabulin In Greater China
August 24, 2021 Roche Tees up $3B+ for Shape's RNA Editing Platform
August 18, 2021 Illumina Acquires GRAIL to Accelerate Patient Access to Life-Saving Multi-Cancer Early-Detection Test
August 4, 2021 BeyondSpring Announces Positive Topline Results From Its DUBLIN-3 Rregistrational Trial Of Plinabulin in Combination with Docetaxel
July 22, 2021 Sema4 Closes Transaction with CM Life Sciences, Debuts as Publicly Traded AI-driven Genomic & Clinical Data Platform Company
July 20, 2021 Pacific Biosciences Signs Definitive Agreement to Acquire Omniome
July 17, 2021 Shape Therapeutics Secures $112 Million in Series B Financing to Advance Breakthrough RNA Technology Platforms to Democratize Gene Therapy
July 15, 2021 AnHeart Therapeutics Announces License Agreement with NewG Lab for Taletrectinib Rights in Korea
July 14, 2021 Cellares and Poseida Therapeutics Partner to Accelerate Cell Therapy
June 23, 2021 Adela Debuts with $60M in Series A Financing and a Breakthrough Approach to Blood-Based Detection of Cancer and Other Diseases
June 2, 2021 SCYNEXIS Announces FDA Approval of BREXAFEMME® (ibrexafungerp tablets) as the First and Only Oral Non-Azole Treatment for Vaginal Yeast Infections
May 31, 2021 Innovent Biologics and AnHeart Therapeutics Jointly Announce Exclusive License Agreement for Taletrectinib in Greater China
May 27, 2021 GenapSys Rakes in $70M for Tabletop Genomic Sequencing Platform
May 17, 2021 Hummingbird Bioscience Raises US$125 Million in Series C Financing
May 17, 2021 Aerpio Pharmaceuticals and Aadi Bioscience Enter into a Definitive Merger Agreement
May 13, 2021 Cue Health Announces Completion of $235 Million Private Financing to Accelerate Growth
May 5, 2021 Cellares Raises $82M To Solve The Biggest Hurdles In Cell Therapy Manufacturing
March 24, 2021 Bioheng Biotech Raised $80 million in Series B Financing to Advance Allogeneic Immuno-Cell Therapies
March 23, 2021 EpimAb Biotherapeutics Raises $120M in Series C Financing to Advance Bispecific Programs and Broaden Clinical Pipeline
March 5, 2021 FDA Authorizes Cue Health’s COVID-19 Test for At-Home and Over The Counter Use
February 10, 2021 Sema4, a Disruptive AI-driven Genomic & Clinical Data Platform Company, to Combine with CM Life Sciences to Accelerate Growth
February 10, 2021 Terns Pharmaceuticals, Inc. Announces Closing of Initial Public Offering and Exercise in Full of Underwriters’ Option to Purchase Additional Shares
February 5, 2021 Equillium Announces Closing of $30 Million Registered Direct Offering
January 6, 2021 LevitasBio Raises $18M in Series B Financing, Forms JV With Thalys Medical in China
January 5, 2021 Lilly-backed Terns raises $87M for multi-front assault on NASH

Archive

  • 2022
  • 2021
  • 2020
  • 2019
  • 2018
  • 2017
  • 2016
  • 2015
  • 2014
  • 2013
  • 2012

    • Silicon Valley
    • Shanghai
    • New York